GEHC
GE HealthCare Technologies Inc.
NASDAQ: GEHC · HEALTHCARE · MEDICAL DEVICES
$59.49
-13.16% today
Updated 2026-04-29
Market cap
$27.06B
P/E ratio
14.27
P/S ratio
1.31x
EPS (TTM)
$4.17
Dividend yield
—
52W range
$59 – $90
Volume
3.9M
WallStSmart proprietary scores
65
out of 100
Grade: B
Buy
Investment rating
4.0
Growth
C4.3
Quality
C7.0
Profitability
B+8.0
Valuation
A2/9
Piotroski F-Score
Weak
1.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$89.74
+50.86%
12-Month target
$70.85
+19.11%
Intrinsic (DCF)
$137.94
Margin of safety
+42.58%
3 Strong Buy11 Buy5 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 22.40% — strong efficiency
+ Free cash flow $917.00M — positive
+ 42.58% below intrinsic value
Risks
- Piotroski 2/9 — weak financial health
- Altman Z 1.34 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $18.34B | $19.55B | $19.67B | $20.63B | $20.63B | $22.1B |
| Net income | $1.92B | $3.10B | $1.99B | $2.08B | $184.00M | — |
| EPS | — | — | — | — | $4.17 | $5.17 |
| Free cash flow | $1.80B | $1.71B | $1.55B | $1.51B | $917.00M | — |
| Profit margin | 10.45% | 15.88% | 10.13% | 10.10% | 10.10% | — |
Peer comparison
Smart narrative
GE HealthCare Technologies Inc. trades at $59.49. representing a P/E of 14.27x trailing earnings. Our Smart Value Score of 65/100 indicates the stock is good. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 1.34, it sits in the distress. TTM revenue stands at $20.63B. with profit margins at 10.10%. Our DCF model estimates intrinsic value at $137.94.
Frequently asked questions
What is GE HealthCare Technologies Inc.'s stock price?
GE HealthCare Technologies Inc. (GEHC) trades at $59.49.
Is GE HealthCare Technologies Inc. overvalued?
Smart Value Score 65/100 (Grade B, Buy). DCF value $137.94.
What is the price target of GE HealthCare Technologies Inc. (GEHC)?
The analyst target price is $89.74, representing +50.9% upside from the current price of $59.49.
What is the intrinsic value of GE HealthCare Technologies Inc. (GEHC)?
Based on our DCF model, intrinsic value is $137.94, a +42.6% margin of safety versus $59.49.
What is the future stock price of GEHC by 2030?
Our research-backed model estimates GE HealthCare Technologies Inc. could reach $703.50 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is GE HealthCare Technologies Inc.'s revenue?
TTM revenue is $20.63B.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
1.34 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.31x
ROE22.40%
Beta1.31
50D MA$73.97
200D MA$76.59
Shares out0.45B
Float0.45B
Short ratio—
Avg volume3.9M
Performance
1 week-13.58%
1 month-17.36%
3 months-24.67%
YTD-27.48%
1 year—
3 years—
5 years—